{"id":"W2092788376","doi":"10.3816/clm.2002.s.006","title":"Acute and Long-Term Toxicities Associated with Gemtuzumab Ozogamicin (Mylotarg®) Therapy of Acute Myeloid Leukemia","year":2002,"lang":"en","type":"review","venue":"Clinical Lymphoma","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Myeloid leukemia; Calicheamicin; Medicine; Leukemia; Pharmacology; Oncology; Internal medicine; CD33; Biology; Stem cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005485048,0.001259037,0.00659026,0.0002997285,0.0001190602,0.00004893789,0.0004970373,0.00154098,0.0003678443],"category_scores_gemma":[0.0002390465,0.0008525389,0.00136248,0.0005633746,0.001010946,0.0001231705,0.0002283817,0.000728361,0.0001068312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003792473,"about_ca_system_score_gemma":0.003181963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003404609,"about_ca_topic_score_gemma":0.00001835733,"domain_scores_codex":[0.9940115,0.0004819529,0.00256045,0.001342626,0.0007656983,0.0008377286],"domain_scores_gemma":[0.9944013,0.001712198,0.001731534,0.001416167,0.0002208775,0.0005179049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005060988,0.0007808047,0.003004184,0.002339523,0.01570144,0.001544941,0.00007050011,5.323472e-8,0.000002317912,0.00001295574,0.000754692,0.9752825],"study_design_scores_gemma":[0.113226,0.02205307,0.1000758,0.1329391,0.07391068,0.007570526,0.00004729254,0.00008954991,0.0001372398,0.00005975518,0.5451201,0.004770799],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.133934,0.8621321,0.000004878889,0.00003378586,0.0003186216,0.002016651,0.0004605383,0.0001759724,0.0009234978],"genre_scores_gemma":[0.00215492,0.9894756,0.0001922637,0.0002726379,0.0003845413,0.0001331333,0.001030791,0.0002724303,0.006083661],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9705117,"threshold_uncertainty_score":0.9997552,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07021262687105202,"score_gpt":0.3669513961079253,"score_spread":0.2967387692368733,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}